MolNFT v2 · #118494 · protein
Cetuximab Fab in complex with F3H meditope variant
5EUK: “Cetuximab Fab in complex with F3H meditope variant”. X-ray diffraction at 2.5, 3 ligands (MRY, NAG, PO4). MolNFT v2 #118494 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5EUK
- Type
- protein
- Length
- 882 residues
- Chains
- 6
- Method
- x-ray diffraction
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
- Resolution
- 2.5
- Source
- MUS MUSCULUS, HOMO SAPIENS; SYNTHETIC CONSTRUCT
- Ligands
- MRY, NAG, PO4
Structure
x-ray diffraction · resolution 2.5 · 5 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 212 | — | — |
| B | — | protein | 220 | — | — |
| C | — | protein | 213 | — | — |
| D | — | protein | 213 | — | — |
| E, F | — | protein | 12 | — | — |
Ligands and binding sites
- MRY · Meso-erythritol · ligand · chains C
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains B, D
- PO4 · Phosphate ion · ion · 4 copies · chains A, B, D
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 5EUK · Cetuximab Fab in complex with F3H meditope variant · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Elsewhere: RCSB PDB 5EUK · PDBe 5EUK
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.